tiprankstipranks
Marker Therapeutics Inc (MRKR)
NASDAQ:MRKR
Holding MRKR?
Track your performance easily

Marker Therapeutics (MRKR) Financial Statements

506 Followers

Marker Therapeutics Financial Overview

Marker Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.081; its P/E ratio is -3.45; Marker Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Jun 23
Income Statement-
Total Revenue$ 1.93M$ 1.17M$ 1.24M$ 3.05M$ 762.66K
Gross Profit$ 1.93M$ 1.17M$ 1.24M$ 1.06M$ 762.66K
EBIT$ -2.31M$ -2.19M$ -2.39M$ -2.94M$ -4.10M
EBITDA$ -2.31M$ -2.19M$ -2.39M$ -2.94M$ -4.10M
Net Income Common Stockholders$ -2.31M$ -2.19M$ -2.39M$ -5.25M$ 2.52M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.00M$ 7.80M$ 11.30M$ 15.10M$ 18.10M
Total Assets$ 10.91M$ 11.68M$ 14.09M$ 17.13M$ 21.96M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -9.00M$ -7.80M$ -11.30M$ -15.10M$ -18.10M
Total Liabilities$ 3.46M$ 1.97M$ 2.30M$ 3.07M$ 2.92M
Stockholders Equity$ 7.45M$ 9.70M$ 11.79M$ 14.05M$ 19.03M
Cash Flow-
Free Cash Flow$ 1.20M$ -3.57M$ -3.84M$ -2.37M$ -7.06M
Operating Cash Flow$ 1.20M$ -3.57M$ -3.84M$ -2.37M$ -7.06M
Investing Cash Flow----$ 18.78M
Financing Cash Flow$ 1.70K$ 44.61K$ 49.10K$ 5.13K$ 736.00
Currency in USD

Marker Therapeutics Earnings and Revenue History

Marker Therapeutics Debt to Assets

Marker Therapeutics Cash Flow

Marker Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis